INSR and type 2 diabetes mellitus: The researchers then investigated the hypoglycaemic mechanism of these two substances and found that they could effectively improve insulin resistance and lower blood glucose through the IRS-1/PI3K/Glut-4 signalling pathway, and that the binding of the insulin receptor (IR) to its corresponding substrates could also affect the activation of one of these signalling mechanisms in type II diabetes.